Delivery Order SPE2DB22D3010-SPE2DB25FP1SW
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX4UG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine DR 1.2 GM Tablets in quantities of 120 per bottle. It is a firm-fixed-price delivery order contract with a ceiling value of $19,431.45 and a period of performance through November 1, 2024. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,027.36, is for the delivery of 120 tablets of 1.2 gram Mesalamine delayed-release (DR) tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of March 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,126.95, is for the delivery of Mesalamine DR 1.2 GM Tablets in quantities of 120 per bottle. The contract has a completion date of February 13, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, with ID SPE2DB22D1202|SPE2DB23FHMS9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine 800 mg delayed-release tablets, with a ceiling value of $4,750.03 and a completion date of May 1, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,368.24, is for the delivery of 120 units of Mesalamine DR 1.2 GM Tablets. This is a firm fixed-price delivery order contract with a completion date of May 5, 2023. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,379,229 units of the drug Mesalamine DR 1.2 GM Tablet 120S. The contract has a total ceiling value of $4,158.84 and is a Firm Fixed Price Delivery Order contract running through February 26, 2025. There was no set-aside designation associated with this award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, with ID SPE2DX15D3404|SPE2DX24F0ZCQ, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to the prime contractor Amerisourcebergen Drug Corp. The $12,756.40 firm fixed-price delivery order is for the procurement of 4,563,239,385 units of the drug Mesalamine DR 1.2 GM Tablet in 120-count packages. The contract has an ultimate completion date of January 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,826.70 firm fixed-price delivery order is for 4,562,867,891 units of the prescription drug Mesalamine DR 1.2 GM Tablet, with a completion date of November 21, 2023. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,226.47 fixed-price delivery order is for the supply of 4,565,481,647 units of the medication Mesalamine DR 1.2 GM Tablet, with a performance period ending on August 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mesalamine delayed-release tablets. The contract, valued at $3,679.63, has a completion date of September 20, 2023 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...